| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 1.92e-06 | 61 | 192 | 7 | GO:1901682 | |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 1.81e-04 | 12 | 192 | 3 | GO:0017154 | |
| GeneOntologyMolecularFunction | RNA 7-methylguanosine cap binding | 2.95e-04 | 14 | 192 | 3 | GO:0000340 | |
| GeneOntologyMolecularFunction | sulfate transmembrane transporter activity | 4.47e-04 | 16 | 192 | 3 | GO:0015116 | |
| GeneOntologyMolecularFunction | ABC-type bile acid transporter activity | 5.45e-04 | 4 | 192 | 2 | GO:0015432 | |
| GeneOntologyMolecularFunction | ATPase-coupled organic acid transmembrane transporter activity | 5.45e-04 | 4 | 192 | 2 | GO:0033283 | |
| GeneOntologyMolecularFunction | ATPase-coupled monocarboxylic acid transmembrane transporter activity | 5.45e-04 | 4 | 192 | 2 | GO:0033285 | |
| GeneOntologyMolecularFunction | ATPase-coupled carboxylic acid transmembrane transporter activity | 5.45e-04 | 4 | 192 | 2 | GO:0033284 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC26A8 SLC22A13 UCP2 SLC35B3 SLC19A2 ABCC11 SLC3A1 SLC26A7 ABCB11 SLC35B1 | 5.63e-04 | 293 | 192 | 10 | GO:0008514 |
| GeneOntologyBiologicalProcess | neuron development | GABRB2 MYO7A INPPL1 CDH23 DSCAML1 TIAM2 NRP2 CYFIP1 PLAA PTPRK VPS13A DIAPH1 DCLK2 CAMSAP2 PLXNA2 CNTN2 CERS2 FN1 KALRN ADAMTS1 APLP2 PIAS2 CYFIP2 AGBL4 FRY ARSB IFT88 CNTNAP2 PLXNA4 CTNNA1 MARK2 ARHGAP33 SOS1 | 1.85e-06 | 1463 | 192 | 33 | GO:0048666 |
| GeneOntologyBiologicalProcess | neuron projection development | MYO7A INPPL1 CDH23 DSCAML1 TIAM2 NRP2 CYFIP1 PLAA PTPRK VPS13A DIAPH1 CAMSAP2 PLXNA2 CNTN2 CERS2 FN1 KALRN ADAMTS1 APLP2 PIAS2 CYFIP2 FRY ARSB IFT88 CNTNAP2 PLXNA4 CTNNA1 MARK2 ARHGAP33 SOS1 | 2.94e-06 | 1285 | 192 | 30 | GO:0031175 |
| GeneOntologyBiologicalProcess | sulfur compound transport | 3.15e-05 | 65 | 192 | 6 | GO:0072348 | |
| GeneOntologyBiologicalProcess | axon development | DSCAML1 TIAM2 NRP2 CYFIP1 DIAPH1 CAMSAP2 PLXNA2 CNTN2 CERS2 FN1 KALRN APLP2 CYFIP2 CNTNAP2 PLXNA4 CTNNA1 MARK2 SOS1 | 3.32e-05 | 642 | 192 | 18 | GO:0061564 |
| GeneOntologyBiologicalProcess | neuromuscular process controlling balance | 6.59e-05 | 74 | 192 | 6 | GO:0050885 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | MYO7A CDH23 DSCAML1 TIAM2 NRP2 CYFIP1 DIAPH1 PLXNA2 CNTN2 FN1 KALRN APLP2 PIAS2 CYFIP2 CNTNAP2 PLXNA4 MARK2 ARHGAP33 SOS1 | 7.53e-05 | 748 | 192 | 19 | GO:0048667 |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | ACADSB MYO5A PDHB NCF1 L2HGDH PGD ENOPH1 ACOX3 PLAA SULT2A1 SLC22A13 HPGD UCP2 SESN2 FH MTCH2 DPYD IDH2 ARSB ABCB11 SMS DSEL PCCB | 9.96e-05 | 1035 | 192 | 23 | GO:0019752 |
| GeneOntologyBiologicalProcess | cell morphogenesis | MYO7A CDH23 DSCAML1 TIAM2 NRP2 CYFIP1 CADM1 PLAA VPS13A DIAPH1 PLXNA2 CNTN2 FN1 KALRN ANXA7 APLP2 PIAS2 CYFIP2 FRY IFT88 CNTNAP2 PLXNA4 MARK2 ARHGAP33 SOS1 | 1.25e-04 | 1194 | 192 | 25 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of cell morphogenesis | CYFIP1 PLAA DIAPH1 PLXNA2 CNTN2 FN1 KALRN ANXA7 PIAS2 PLXNA4 MARK2 | 1.30e-04 | 302 | 192 | 11 | GO:0022604 |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | ACADSB MYO5A PDHB NCF1 L2HGDH PGD ENOPH1 ACOX3 PLAA SULT2A1 SLC22A13 HPGD UCP2 SESN2 FH MTCH2 DPYD IDH2 ARSB ABCB11 SMS DSEL PCCB | 1.38e-04 | 1058 | 192 | 23 | GO:0043436 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | ACADSB MYO5A PDHB NCF1 L2HGDH PGD ENOPH1 ACOX3 PLAA SULT2A1 SLC22A13 HPGD UCP2 SESN2 FH MTCH2 DPYD IDH2 ARSB ABCB11 SMS DSEL PCCB | 1.50e-04 | 1064 | 192 | 23 | GO:0006082 |
| GeneOntologyCellularComponent | apical part of cell | MYO7A CDH23 SLC22A13 ADGRF5 HSD11B1 CACNA1D MGAM NAALADL1 FN1 ABCC11 SLC3A1 SLC15A1 SLC26A7 ABCB11 ATP12A CTSB | 1.28e-04 | 592 | 193 | 16 | GO:0045177 |
| GeneOntologyCellularComponent | semaphorin receptor complex | 2.07e-04 | 13 | 193 | 3 | GO:0002116 | |
| Domain | Cytoplasmic_FMR1-int | 1.04e-04 | 2 | 191 | 2 | IPR008081 | |
| Domain | FragX_IP | 1.04e-04 | 2 | 191 | 2 | PF05994 | |
| Domain | VWFA | 1.94e-04 | 82 | 191 | 6 | PS50234 | |
| Domain | VWA | 2.22e-04 | 84 | 191 | 6 | SM00327 | |
| Domain | VWA | 2.66e-04 | 56 | 191 | 5 | PF00092 | |
| Domain | DH_1 | 4.61e-04 | 63 | 191 | 5 | PS00741 | |
| Domain | VWF_A | 5.39e-04 | 99 | 191 | 6 | IPR002035 | |
| Domain | UAA | 6.16e-04 | 4 | 191 | 2 | IPR013657 | |
| Domain | Glyco_hydro_31_CS | 6.16e-04 | 4 | 191 | 2 | IPR030459 | |
| Domain | DUF1394 | 6.16e-04 | 4 | 191 | 2 | IPR009828 | |
| Domain | Gal_mutarotase_N | 6.16e-04 | 4 | 191 | 2 | IPR031727 | |
| Domain | DUF1394 | 6.16e-04 | 4 | 191 | 2 | PF07159 | |
| Domain | UAA | 6.16e-04 | 4 | 191 | 2 | PF08449 | |
| Domain | NtCtMGAM_N | 6.16e-04 | 4 | 191 | 2 | PF16863 | |
| Domain | MAM | 6.44e-04 | 17 | 191 | 3 | SM00137 | |
| Domain | RhoGEF | 6.57e-04 | 68 | 191 | 5 | SM00325 | |
| Domain | RhoGEF | 7.50e-04 | 70 | 191 | 5 | PF00621 | |
| Domain | DH_2 | 7.50e-04 | 70 | 191 | 5 | PS50010 | |
| Domain | MAM | 7.67e-04 | 18 | 191 | 3 | PF00629 | |
| Domain | MAM_dom | 7.67e-04 | 18 | 191 | 3 | IPR000998 | |
| Domain | MAM_2 | 7.67e-04 | 18 | 191 | 3 | PS50060 | |
| Domain | Ig_I-set | 7.70e-04 | 190 | 191 | 8 | IPR013098 | |
| Domain | I-set | 7.70e-04 | 190 | 191 | 8 | PF07679 | |
| Domain | - | 8.00e-04 | 71 | 191 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 8.00e-04 | 71 | 191 | 5 | IPR000219 | |
| Pubmed | REPS1 MYO1E MYO5A PDHB TTLL5 ANKS1B DSCAML1 PSMG2 CADM1 PTPRK DCLK2 CHD6 DOP1B ARMC8 AKAP6 FN1 KALRN ADAMTS1 USP28 ANXA7 PIAS2 FRY IFT88 ARHGEF10 CTNNA1 CTSB PCCB SOS1 | 6.97e-10 | 1285 | 193 | 28 | 35914814 | |
| Pubmed | MYO1E MYO5A MYO7A PDHB ANKS1B CYFIP1 DCLK2 FH CAMSAP2 DNAH6 HSPA4 MTCH2 AP3D1 CNTN2 ARMC8 SGIP1 FN1 KALRN HSPA4L GEMIN5 IDH2 VIRMA CYFIP2 AGBL4 PLXNA4 TMOD1 CTNNA1 MARK2 CACNA2D3 | 1.74e-09 | 1431 | 193 | 29 | 37142655 | |
| Pubmed | REPS1 MYO5A SF3A1 INPPL1 TIAM2 CYFIP1 PKP2 MTCH2 HSPA4L ANXA5 VIRMA ARHGEF10L NUP35 ARHGEF10 TPX2 TMOD1 CTNNA1 ARHGAP33 SOS1 | 9.68e-07 | 916 | 193 | 19 | 32203420 | |
| Pubmed | 1.67e-06 | 5 | 193 | 3 | 22593055 | ||
| Pubmed | Evaluation of candidate genes in a genome-wide association study of childhood asthma in Mexicans. | 1.67e-06 | 5 | 193 | 3 | 19910030 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | ACADSB PAQR5 L2HGDH NRP2 TMEM70 VPS13A FH CAMSAP2 PIGO CERS2 ANXA5 SLC19A2 APOB SMS CTNNA1 MARK2 SLC45A1 ATP12A CTSB PCCB | 2.14e-06 | 1061 | 193 | 20 | 33845483 |
| Pubmed | 2.42e-06 | 69 | 193 | 6 | 32238831 | ||
| Pubmed | 3.32e-06 | 6 | 193 | 3 | 28438183 | ||
| Pubmed | 3.32e-06 | 6 | 193 | 3 | 30482882 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | REPS1 PDHB SF3A1 INPPL1 ACOX3 PHKA1 CYFIP1 HSPA4 MTCH2 HSPA4L TNS2 CYFIP2 CSK AIFM1 TPX2 MARK2 MAP2K5 SOS1 | 3.67e-06 | 910 | 193 | 18 | 36736316 |
| Pubmed | 3.70e-06 | 162 | 193 | 8 | 25826454 | ||
| Pubmed | 4.27e-06 | 220 | 193 | 9 | 24550385 | ||
| Pubmed | Role of myosin VIIa and Rab27a in the motility and localization of RPE melanosomes. | 5.79e-06 | 7 | 193 | 3 | 15572405 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | MYO5A MYO7A ANKS1B CDH23 ISG20 CNOT6 CYFIP1 CADM1 VPS13A PLXNA2 DOP1B ANKRD13D TMEM126A SEC22B PIAS2 VIRMA CYFIP2 NACC2 CLDN16 TMOD1 SMS | 6.32e-06 | 1242 | 193 | 21 | 30973865 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | PDHB SF3A1 TMPRSS11B NRP2 PTPRK TMEM70 C1R DNAH6 MTCH2 AP3D1 PIGO CERS2 TMEM126A FN1 ADAMTS1 SEC22B ADAMTS5 IDH2 CYFIP2 ARSB AIFM1 CTSB GAA | 6.41e-06 | 1451 | 193 | 23 | 30550785 |
| Pubmed | 6.55e-06 | 175 | 193 | 8 | 28071719 | ||
| Pubmed | Spike S1 domain interactome in non-pulmonary systems: A role beyond the receptor recognition. | 8.72e-06 | 182 | 193 | 8 | 36225252 | |
| Pubmed | Integration of opposing semaphorin guidance cues in cortical axons. | 9.23e-06 | 8 | 193 | 3 | 22368082 | |
| Pubmed | 9.39e-06 | 87 | 193 | 6 | 33711283 | ||
| Pubmed | 1.05e-05 | 52 | 193 | 5 | 26633812 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | PGD DIAPH1 FH HSPA4 MTCH2 AP3D1 CERS2 ANXA5 IDH2 CYFIP2 EPG5 AIFM1 SMS CTNNA1 PCCB DISP1 | 1.26e-05 | 807 | 193 | 16 | 30575818 |
| Pubmed | 1.38e-05 | 9 | 193 | 3 | 19909241 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | GABRB2 PGD TIAM2 SLC22A13 HPGD DOP1B FN1 KALRN ANXA5 ANXA7 ABCC11 PKD1L3 CYFIP2 SLC3A1 EYS CSK ABCB11 GAA | 1.63e-05 | 1016 | 193 | 18 | 19056867 |
| Pubmed | REPS1 MYO1E ACADSB NCF1 L2HGDH NKRF PSMG2 HSPA4 AP3D1 ARMC8 CERS2 HSPA4L ANXA5 ANXA7 GEMIN5 SEC22B IDH2 AIFM1 TMEM209 TMOD1 CTNNA1 CTSB | 1.82e-05 | 1440 | 193 | 22 | 30833792 | |
| Pubmed | Plexin A3 and plexin A4 convey semaphorin signals during facial nerve development. | 1.96e-05 | 10 | 193 | 3 | 18804103 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MYO5A PDHB SF3A1 PGD GTF3C3 PHKA1 CYFIP1 DIAPH1 HSPA4 AP3D1 NAA15 ADAMTS1 HSPA4L ANXA5 GEMIN5 IDH2 NOL9 CYFIP2 CTSB | 2.42e-05 | 1149 | 193 | 19 | 35446349 |
| Pubmed | 2.47e-05 | 103 | 193 | 6 | 21706016 | ||
| Pubmed | 2.69e-05 | 11 | 193 | 3 | 38750698 | ||
| Pubmed | ACADSB PDHB PGD PKP2 FH HSPA4 MTCH2 PMS1 ANXA5 SEC22B IDH2 CYFIP2 AIFM1 PLXNA4 CTSB PCCB | 2.69e-05 | 859 | 193 | 16 | 31536960 | |
| Pubmed | ACADSB MYO5A PDHB SF3A1 TTLL5 PGD GTF3C3 VPS13A HSPA4 AP3D1 PMS1 TMEM126A NAA15 HSPA4L SEC22B NOL9 ARHGEF10 AIFM1 TMEM209 CTNNA1 MARK2 EDRF1 | 2.96e-05 | 1487 | 193 | 22 | 33957083 | |
| Pubmed | Meiotic gatekeeper STRA8 regulates cell cycle by interacting with SETD8 during spermatogenesis. | 3.06e-05 | 2 | 193 | 2 | 32090428 | |
| Pubmed | Genetic variants in autism-related CNTNAP2 impair axonal growth of cortical neurons. | 3.06e-05 | 2 | 193 | 2 | 29788201 | |
| Pubmed | Different dysregulations of CYFIP1 and CYFIP2 in distinct types of dementia. | 3.06e-05 | 2 | 193 | 2 | 38128786 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 10524232 | ||
| Pubmed | The juxtaparanodal proteins CNTNAP2 and TAG1 regulate diet-induced obesity. | 3.06e-05 | 2 | 193 | 2 | 22752552 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 17283063 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 14648237 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 29979793 | ||
| Pubmed | [Usher type I syndrome in children: genotype/phenotype correlation and cochlear implant benefits]. | 3.06e-05 | 2 | 193 | 2 | 18323324 | |
| Pubmed | Cdh23 mutations in the mouse are associated with retinal dysfunction but not retinal degeneration. | 3.06e-05 | 2 | 193 | 2 | 14609561 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 19911372 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 12391193 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 1183472 | ||
| Pubmed | Cytoplasmic FMRP interacting protein 1/2 (CYFIP1/2) expression analysis in autism. | 3.06e-05 | 2 | 193 | 2 | 29752658 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 26217189 | ||
| Pubmed | Polymorphisms of POR, SULT2A1 and HSD11B1 in children with premature adrenarche. | 3.06e-05 | 2 | 193 | 2 | 22445027 | |
| Pubmed | Mutation analysis of the MYO7A and CDH23 genes in Japanese patients with Usher syndrome type 1. | 3.06e-05 | 2 | 193 | 2 | 20844544 | |
| Pubmed | Myosin Va is required for normal photoreceptor synaptic activity. | 3.06e-05 | 2 | 193 | 2 | 15316067 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 39122105 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 28818524 | ||
| Pubmed | ANKS1B is a smoking-related molecular alteration in clear cell renal cell carcinoma. | 3.06e-05 | 2 | 193 | 2 | 24479813 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 11829495 | ||
| Pubmed | C57BL/6N mutation in cytoplasmic FMRP interacting protein 2 regulates cocaine response. | 3.06e-05 | 2 | 193 | 2 | 24357318 | |
| Pubmed | Inner hair cells are not required for survival of spiral ganglion neurons in the adult cochlea. | 3.06e-05 | 2 | 193 | 2 | 22238076 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 29737873 | ||
| Pubmed | Fine mapping of the uterine leiomyoma locus on 1q43 close to a lncRNA in the RGS7-FH interval. | 3.06e-05 | 2 | 193 | 2 | 26113603 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 10984423 | ||
| Pubmed | Myosin Va interacts with the exosomal protein spermine synthase. | 3.06e-05 | 2 | 193 | 2 | 30733278 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 34327661 | ||
| Pubmed | Stereocilia defects in waltzer (Cdh23), shaker1 (Myo7a) and double waltzer/shaker1 mutant mice. | 3.06e-05 | 2 | 193 | 2 | 12121736 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 26888488 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 35567753 | ||
| Pubmed | Heat shock protein-70 neutralizes apoptosis inducing factor in Bcr/Abl expressing cells. | 3.06e-05 | 2 | 193 | 2 | 26165468 | |
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 26188518 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 31324746 | ||
| Pubmed | 3.06e-05 | 2 | 193 | 2 | 27621318 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | MYO5A PGD CYFIP1 MGAT5 C1R DOP1B MGAM FN1 ANXA5 ANXA7 APOB IDH2 CYFIP2 ARSB HMCN1 SMS CTSB GAA | 3.21e-05 | 1070 | 193 | 18 | 23533145 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DUSP12 PDHB PGD CYFIP1 PTPRK HSPA4 MTCH2 ARMC8 NAA15 HSPA4L TNS2 APLP2 SEC22B CSK SMS CTNNA1 MARK2 | 3.40e-05 | 974 | 193 | 17 | 28675297 |
| Pubmed | IKK-Mediated Regulation of the COP9 Signalosome via Phosphorylation of CSN5. | 3.53e-05 | 221 | 193 | 8 | 31950832 | |
| Pubmed | On and off retinal circuit assembly by divergent molecular mechanisms. | 3.57e-05 | 12 | 193 | 3 | 24179230 | |
| Pubmed | 3.57e-05 | 12 | 193 | 3 | 25839327 | ||
| Pubmed | 3.57e-05 | 12 | 193 | 3 | 28407732 | ||
| Pubmed | Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina. | 3.57e-05 | 12 | 193 | 3 | 21270798 | |
| Pubmed | 3.63e-05 | 288 | 193 | 9 | 23383273 | ||
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 3.65e-05 | 67 | 193 | 5 | 21875946 | |
| Pubmed | 4.35e-05 | 167 | 193 | 7 | 22159717 | ||
| Pubmed | 4.38e-05 | 114 | 193 | 6 | 28245920 | ||
| Pubmed | Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation. | 4.62e-05 | 13 | 193 | 3 | 22723296 | |
| Pubmed | Functional assembly of accessory optic system circuitry critical for compensatory eye movements. | 4.62e-05 | 13 | 193 | 3 | 25959730 | |
| Pubmed | 4.62e-05 | 13 | 193 | 3 | 10520995 | ||
| Pubmed | TRAF4 acts as a silencer in TLR-mediated signaling through the association with TRAF6 and TRIF. | 4.62e-05 | 13 | 193 | 3 | 16052631 | |
| Pubmed | MYO5A MYO7A PDHB PGD NRP2 CYFIP1 HPGD FH HSPA4 NAA15 DPP10 ANXA5 SEC22B IDH2 CTSB | 4.68e-05 | 803 | 193 | 15 | 36517590 | |
| Pubmed | 4.68e-05 | 230 | 193 | 8 | 35449600 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PDHB SF3A1 PGD GTF3C3 CYFIP1 DIAPH1 FH HSPA4 MTCH2 ARMC8 HSPA4L ANXA5 GEMIN5 APLP2 SEC22B APOB IDH2 NOL9 CYFIP2 NUP35 AIFM1 | 4.80e-05 | 1425 | 193 | 21 | 30948266 |
| Pubmed | FSIP1 ANKS1B ISG20 CADM1 PKP2 PMS1 DPP10 TACC2 RGS7 DENND3 ARHGEF10L RHPN2 CNTNAP2 TMOD1 ATP12A | 5.45e-05 | 814 | 193 | 15 | 23251661 | |
| Pubmed | A midline switch of receptor processing regulates commissural axon guidance in vertebrates. | 5.85e-05 | 14 | 193 | 3 | 20159958 | |
| Pubmed | 5.85e-05 | 14 | 193 | 3 | 8022818 | ||
| Pubmed | 6.73e-05 | 312 | 193 | 9 | 37120454 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYO5A PDHB PGD NKRF GTF3C3 CYFIP1 PLAA A2ML1 DIAPH1 PKP2 PLCG2 HSPA4 AP3D1 NAA15 FN1 ANXA5 GEMIN5 SEC22B NOL9 AIFM1 | 7.03e-05 | 1353 | 193 | 20 | 29467282 |
| Pubmed | REPS1 ACADSB PDHB SF3A1 INPPL1 NKRF CYFIP1 DIAPH1 PKP2 FH CAMSAP2 HSPA4 MTCH2 HSPA4L ANXA5 CYFIP2 AIFM1 CTNNA1 MARK2 | 7.24e-05 | 1247 | 193 | 19 | 27684187 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | PHKA1 A2ML1 CHD6 HSPA4 AP3D1 NAA15 FN1 KALRN HSPA4L IDH2 FRY | 7.70e-05 | 475 | 193 | 11 | 31040226 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | PDHB SF3A1 PGD ENOPH1 CYFIP1 CADM1 PLAA A2ML1 FH HSPA4 MTCH2 NAA15 ANXA7 GEMIN5 SEC22B NOL9 AIFM1 CTNNA1 CTSB GAA | 8.08e-05 | 1367 | 193 | 20 | 32687490 |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | MYO1E SF3A1 PGD GTF3C3 AP3D1 TMEM126A NOL9 VIRMA CTNNA1 MARK2 | 8.75e-05 | 400 | 193 | 10 | 35013556 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | MYO1E CADM1 PKP2 PLXNA2 IGSF3 ANXA7 APLP2 APOB SLC15A1 RHPN2 CCDC25 MARK2 | 8.85e-05 | 569 | 193 | 12 | 30639242 |
| Pubmed | Expression of the semaphorins Sema 3D and Sema 3F in the developing parathyroid and thymus. | 8.93e-05 | 16 | 193 | 3 | 18489001 | |
| Pubmed | TAG-1 Multifunctionality Coordinates Neuronal Migration, Axon Guidance, and Fasciculation. | 8.93e-05 | 16 | 193 | 3 | 31995756 | |
| Pubmed | PGD TIAM2 CHD6 PLCG2 MTCH2 PMS1 KMT5A ANXA5 SEC22B APOB NOL9 ZNF12 TPX2 TMOD1 | 8.95e-05 | 754 | 193 | 14 | 35906200 | |
| Pubmed | 9.16e-05 | 3 | 193 | 2 | 27397516 | ||
| Pubmed | 9.16e-05 | 3 | 193 | 2 | 17296555 | ||
| Pubmed | 9.16e-05 | 3 | 193 | 2 | 19236842 | ||
| Interaction | PKD1 interactions | 6.56e-07 | 53 | 191 | 7 | int:PKD1 | |
| Interaction | ART3 interactions | 7.16e-06 | 29 | 191 | 5 | int:ART3 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.08e-04 | 66 | 129 | 5 | 722 | |
| GeneFamily | Solute carriers | SLC26A8 SLC22A13 UCP2 MTCH2 SLC35B3 SLC19A2 SLC3A1 SLC15A1 SLC26A7 SLC45A1 SLC35B1 | 1.25e-04 | 395 | 129 | 11 | 752 |
| GeneFamily | Immunoglobulin like domain containing | 4.73e-04 | 193 | 129 | 7 | 594 | |
| GeneFamily | Fibronectin type III domain containing | 1.02e-03 | 160 | 129 | 6 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.05e-03 | 161 | 129 | 6 | 593 | |
| GeneFamily | BEN domain containing | 1.76e-03 | 9 | 129 | 2 | 422 | |
| GeneFamily | Plexins | 1.76e-03 | 9 | 129 | 2 | 683 | |
| Coexpression | GSE16385_MONOCYTE_VS_MACROPHAGE_DN | GABRB2 TIAM2 MGAT5 PTPRE HSD11B1 RAB39B NMNAT1 KALRN TSPAN32 SLC26A7 | 2.48e-06 | 200 | 193 | 10 | M7901 |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_DN | 1.85e-05 | 200 | 193 | 9 | M3929 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_DC_DN | 1.85e-05 | 200 | 193 | 9 | M4492 | |
| Coexpression | TRAVAGLINI_LUNG_TREM2_DENDRITIC_CELL | NCF1 PGD CYFIP1 TMEM70 HSD11B1 MTCH2 FN1 CD300LF ANXA5 APLP2 ARHGEF10L SMS CTNNA1 CTSB GAA | 2.40e-05 | 572 | 193 | 15 | M41698 |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S3 | 3.00e-05 | 266 | 193 | 10 | M1286 | |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | ZNF777 ACADSB MYO5A MYO7A SVEP1 TIAM2 PTPRK TSEN15 MOCOS TMEM126A COL12A1 FN1 PIAS2 RGS7 EPG5 ARSB AIFM1 KLHDC8A PCCB DISP1 SLC35B1 SOS1 | 3.55e-05 | 1136 | 193 | 22 | M2247 |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | NRP2 DIAPH1 C1R MTCH2 IGSF3 FN1 ANXA7 SLC19A2 APLP2 ADAMTS5 CTNNA1 CTSB GAA | 3.72e-05 | 457 | 193 | 13 | M1613 |
| Coexpression | GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_UP | 4.67e-05 | 174 | 193 | 8 | M397 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | NRP2 DIAPH1 C1R MTCH2 IGSF3 FN1 ANXA7 SLC19A2 APLP2 ADAMTS5 CTNNA1 CTSB GAA | 4.95e-05 | 470 | 193 | 13 | MM1053 |
| Coexpression | GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_UP | 6.17e-05 | 181 | 193 | 8 | M6323 | |
| Coexpression | GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP | 7.75e-05 | 187 | 193 | 8 | M6807 | |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | ZNF777 ACADSB MYO5A MYO7A SVEP1 TIAM2 PTPRK TSEN15 MOCOS TMEM126A COL12A1 FN1 PIAS2 RGS7 EPG5 ARSB AIFM1 KLHDC8A PCCB DISP1 SLC35B1 SOS1 | 7.76e-05 | 1198 | 193 | 22 | MM1062 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP | PDHB PGD CYFIP1 GRK3 UCP2 AP3D1 DPYD APLP2 SEC22B IDH2 CSK TMEM209 CTNNA1 CTSB | 7.80e-05 | 562 | 193 | 14 | M41008 |
| Coexpression | GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_DN | 1.15e-04 | 198 | 193 | 8 | M6516 | |
| Coexpression | GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP | 1.19e-04 | 199 | 193 | 8 | M9754 | |
| Coexpression | GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN | 1.19e-04 | 199 | 193 | 8 | M6066 | |
| Coexpression | GSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_DN | 1.24e-04 | 200 | 193 | 8 | M8576 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_UP | 1.24e-04 | 200 | 193 | 8 | M7431 | |
| Coexpression | GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_UP | 1.24e-04 | 200 | 193 | 8 | M7903 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN | 1.24e-04 | 200 | 193 | 8 | M4480 | |
| Coexpression | GSE40274_HELIOS_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 1.24e-04 | 200 | 193 | 8 | M9166 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | MYO1E NRP2 PTPRK C1R ADGRF5 DNAH6 PLXNA2 COL12A1 FN1 ADAMTS1 TNS2 APLP2 ADAMTS5 HMCN1 ARHGEF10 PLXNA4 | 2.74e-06 | 450 | 188 | 16 | GSM777063_500 |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | MYO1E NRP2 PTPRK C1R ADGRF5 DNAH6 PLXNA2 COL12A1 FN1 ADAMTS1 TNS2 APLP2 HMCN1 ARHGEF10 PLXNA4 | 9.11e-06 | 439 | 188 | 15 | GSM777059_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | ZFP42 FSIP1 STRA8 TTLL5 NKRF PHKA1 PLAA VPS13A DCLK2 PLCG2 WDR44 PMS1 HSPA4L USP28 RHPN2 AIFM1 TMEM209 CCDC25 SMS EDRF1 | 4.22e-05 | 820 | 188 | 20 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | PAQR5 CADM1 MGAT5 CACNA1D SGIP1 IDH2 RGS7 CYFIP2 CLDN16 CACNA2D3 | 9.29e-09 | 187 | 192 | 10 | b93cf4dfe8ffb89348ee7bccc9f284189f7240a2 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | PAQR5 DSCAML1 CADM1 MGAT5 SGIP1 COL28A1 IDH2 CYFIP2 CLDN16 CACNA2D3 | 1.08e-08 | 190 | 192 | 10 | 3dcadabbefe0128a5f30ab51234f049ab4d870c6 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | PAQR5 DSCAML1 CADM1 MGAT5 SGIP1 COL28A1 IDH2 CYFIP2 CLDN16 CACNA2D3 | 1.20e-08 | 192 | 192 | 10 | 562df5e87038c500dd3a003fe5374cb31946b145 |
| ToppCell | healthy_donor-Myeloid-Monocytic-CD14+_Monocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.76e-08 | 200 | 192 | 10 | e4f4ac674f3e085f52c6affeb6aeadaec7fffa73 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-08 | 172 | 192 | 9 | 51bea97564a33f0060c546c9be4bf8bf8f1660f6 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-08 | 172 | 192 | 9 | be4dd4ba8d7a651677c797c25fd75f14e627415a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | PAQR5 DSCAML1 CADM1 MGAT5 SGIP1 COL28A1 IDH2 CYFIP2 CACNA2D3 | 7.28e-08 | 175 | 192 | 9 | e5467dacf81f1f913b1719931cf1a7331434a7e7 |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-08 | 175 | 192 | 9 | c8cfe0ac0c1ac447c626a623cc49692a0b177a1c | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-08 | 175 | 192 | 9 | 61fbd8f685d3daad46449e4c0386a38886496566 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-07 | 183 | 192 | 9 | 31ab55d5f3639f5964541d5eae23044dbda3356e | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.28e-07 | 187 | 192 | 9 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.68e-07 | 193 | 192 | 9 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.83e-07 | 195 | 192 | 9 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.00e-07 | 197 | 192 | 9 | d7cef7881abd807a679432766ced609a6efd1067 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.00e-07 | 197 | 192 | 9 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.00e-07 | 197 | 192 | 9 | 20a5958512bdb99daeb8f4d244df53e4f048f879 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.08e-07 | 198 | 192 | 9 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.08e-07 | 198 | 192 | 9 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 2.08e-07 | 198 | 192 | 9 | e0e47cf65774191981840b22905b2094b95abe0f | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.17e-07 | 199 | 192 | 9 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-07 | 200 | 192 | 9 | 933b5b400e48a511ba0a056be1d33d3610b5f10d | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-07 | 200 | 192 | 9 | f6cf98aad53aa8b3fa02cf874d6f7cd75530a213 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D122|Adult / Lineage, Cell type, age group and donor | 2.69e-07 | 148 | 192 | 8 | 81a1e6fdd942a612bf523c59b8b4974f6ca1fdce | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.87e-07 | 160 | 192 | 8 | 9f1fec2cf565193c73cc3c8a4f0476e57478e3b8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.35e-07 | 162 | 192 | 8 | 285e6d553f485fd9f1075c4e1b940da251b5ea35 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-non-classical_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.61e-07 | 163 | 192 | 8 | f6c8db5963ee1f8e0c2996f1aeecd58c00e9b099 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.61e-07 | 163 | 192 | 8 | cab65dabeea58141c649e4fec5e0123beb3de1b3 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.88e-07 | 164 | 192 | 8 | ea2897942ad72fba900c7ab354d6a9e203bf0e4a | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.38e-07 | 169 | 192 | 8 | 44d841fd997a6f26104f16cd00223ecce8352f43 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-non-classical_monocyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.06e-07 | 171 | 192 | 8 | 00739085fdbc4d64c9faacba2c2adeab580dd2b1 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.43e-07 | 172 | 192 | 8 | 5f58ff6cac32546d07b2a49ed250b6c7aa417188 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-06 | 180 | 192 | 8 | a17dbe03597b81e7a1fe2bf2d23e59e55c615a2a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-06 | 180 | 192 | 8 | eee71184ebed2694d3e60f579a44b3cf7dd2cd35 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-06 | 181 | 192 | 8 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.29e-06 | 182 | 192 | 8 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.34e-06 | 183 | 192 | 8 | f9a3af96c0fb7d5c4d7df6db8b2c42e322418c08 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 184 | 192 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-06 | 184 | 192 | 8 | e8238fe58f94b4f5700ab7f343fb06ea61e899a9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 184 | 192 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 184 | 192 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-06 | 186 | 192 | 8 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.58e-06 | 187 | 192 | 8 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-06 | 188 | 192 | 8 | 3cee9916399e2e7580cecbcbb27424a71e7e7ac0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-06 | 189 | 192 | 8 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.71e-06 | 189 | 192 | 8 | a75226616340045b581d08429d2e123e041dee55 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-06 | 190 | 192 | 8 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-06 | 191 | 192 | 8 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-06 | 191 | 192 | 8 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.92e-06 | 192 | 192 | 8 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 2.00e-06 | 193 | 192 | 8 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.00e-06 | 193 | 192 | 8 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.00e-06 | 193 | 192 | 8 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.00e-06 | 193 | 192 | 8 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-06 | 193 | 192 | 8 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 2.08e-06 | 194 | 192 | 8 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-06 | 194 | 192 | 8 | 8fae8061b350336299aa81f378e07deadbd55123 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.08e-06 | 194 | 192 | 8 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 2.08e-06 | 194 | 192 | 8 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.08e-06 | 194 | 192 | 8 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-06 | 194 | 192 | 8 | c95d5c4ad0210ebd672926558cc8331e6396a854 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-06 | 194 | 192 | 8 | 4d7d24390fdb379f943ddcc70a63f23955e10163 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.16e-06 | 195 | 192 | 8 | 0110b976f98561ecd2e20ff6e7e3960a401bb7c2 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.16e-06 | 195 | 192 | 8 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-06 | 195 | 192 | 8 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.16e-06 | 195 | 192 | 8 | 050fc59b328391d6e3ce23051764a842dcbb3144 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-06 | 196 | 192 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.24e-06 | 196 | 192 | 8 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-06 | 196 | 192 | 8 | 90edf61116ffcb4f8b6be3d0a05732d59b0a87d5 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.24e-06 | 196 | 192 | 8 | 28e9e191361966df3a9bd48450090577aa72a999 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-06 | 196 | 192 | 8 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-06 | 196 | 192 | 8 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-06 | 196 | 192 | 8 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-06 | 196 | 192 | 8 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-06 | 196 | 192 | 8 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.33e-06 | 197 | 192 | 8 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.33e-06 | 197 | 192 | 8 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-06 | 197 | 192 | 8 | 4ea3f57cd88b8a6bb7cb4b9e3545c0fa8f331886 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.33e-06 | 197 | 192 | 8 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.33e-06 | 197 | 192 | 8 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.33e-06 | 197 | 192 | 8 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.33e-06 | 197 | 192 | 8 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.33e-06 | 197 | 192 | 8 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.33e-06 | 197 | 192 | 8 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 2.42e-06 | 198 | 192 | 8 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.42e-06 | 198 | 192 | 8 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.42e-06 | 198 | 192 | 8 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.42e-06 | 198 | 192 | 8 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.42e-06 | 198 | 192 | 8 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | mild-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.51e-06 | 199 | 192 | 8 | d0d286eafe935f9b3aaba5b783e8911251121b4a | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.51e-06 | 199 | 192 | 8 | 28c1722deef3b8347371c7359be7c64b95780de3 | |
| ToppCell | healthy_donor-Myeloid-Monocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.51e-06 | 199 | 192 | 8 | bd66a8d1a7cc92313328acc7c7ae0442faff951e | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.51e-06 | 199 | 192 | 8 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.51e-06 | 199 | 192 | 8 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.51e-06 | 199 | 192 | 8 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.51e-06 | 199 | 192 | 8 | dbf0bf09896c46155ae6fbd6307f097799e7e34e | |
| ToppCell | PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.51e-06 | 199 | 192 | 8 | 9314eb9a89407738626a0384884454b5f9031ee7 | |
| ToppCell | BAL-Control-cDC_0|Control / Compartment, Disease Groups and Clusters | 2.51e-06 | 199 | 192 | 8 | 4518ffa51ead9da1ddf07bf048b18602e50f0f84 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.51e-06 | 199 | 192 | 8 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-iNKT-MAIT|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.51e-06 | 199 | 192 | 8 | 0986d4342dc61e623d0dfc9f9870af86f72a8be3 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.51e-06 | 199 | 192 | 8 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| Disease | Colorectal Carcinoma | SF3A1 DSCAML1 CABYR VPS13A SESN2 CAMSAP2 PIGO AKAP6 DPYD FN1 KALRN APOB ARHGEF10L RHPN2 TPX2 ABCB11 DSEL EDRF1 | 7.56e-07 | 702 | 190 | 18 | C0009402 |
| Disease | FEV/FEC ratio | ANKS1B CDH23 NRP2 CADM1 MGAT5 HSPA4 AP3D1 CNTN2 AKAP6 CACNA1D MGAM NAA15 ADAMTS1 SLC35B3 ADAMTS5 DENND3 CYFIP2 AGBL4 HMCN1 CNTNAP2 TMOD1 IL1RL1 CACNA2D3 | 4.66e-06 | 1228 | 190 | 23 | EFO_0004713 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 6.78e-06 | 152 | 190 | 8 | DOID:0060041 (implicated_via_orthology) | |
| Disease | myocardial infarction | DCLK2 PLCG2 AP3D1 FN1 KALRN APOB PKD1L3 SLC15A1 CSK PCCB GAA | 1.84e-05 | 350 | 190 | 11 | EFO_0000612 |
| Disease | chromosome 15q11.2 deletion syndrome (implicated_via_orthology) | 1.23e-04 | 3 | 190 | 2 | DOID:0060393 (implicated_via_orthology) | |
| Disease | a disintegrin and metalloproteinase with thrombospondin motifs 5 measurement | 1.23e-04 | 3 | 190 | 2 | EFO_0008326 | |
| Disease | Intellectual Disability | GABRB2 PUS3 L2HGDH GTF3C3 DIAPH1 RAB39B TSEN15 AKAP6 NAA15 RGS7 FRY | 1.64e-04 | 447 | 190 | 11 | C3714756 |
| Disease | coronary artery calcification | MYO1E SF3A1 HPGD DNAH6 HSPA4 SLC35B3 APOB FRY EYS IFT88 CACNA2D3 | 1.74e-04 | 450 | 190 | 11 | EFO_0004723 |
| Disease | alcohol dependence, heroin dependence, methamphetamine dependence | 2.45e-04 | 4 | 190 | 2 | EFO_0004240, EFO_0004701, MONDO_0007079 | |
| Disease | Combined D-2- and L-2-hydroxyglutaric aciduria | 2.45e-04 | 4 | 190 | 2 | C2746066 | |
| Disease | aspartate aminotransferase measurement | MYO7A PDHB STRA8 L2HGDH CADM1 MGAT5 MTCH2 CNTN2 MOCOS CERS2 KALRN MANEA AGBL4 CNTNAP2 ABCB11 SOS1 | 2.67e-04 | 904 | 190 | 16 | EFO_0004736 |
| Disease | Usher syndrome, type 1A | 4.07e-04 | 5 | 190 | 2 | C2931205 | |
| Disease | marginal zone B-cell lymphoma, systemic lupus erythematosus | 4.07e-04 | 5 | 190 | 2 | EFO_1000630, MONDO_0007915 | |
| Disease | USHER SYNDROME, TYPE IB (disorder) | 4.07e-04 | 5 | 190 | 2 | C1848638 | |
| Disease | USHER SYNDROME, TYPE IA, FORMERLY | 4.07e-04 | 5 | 190 | 2 | C1848639 | |
| Disease | USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY | 4.07e-04 | 5 | 190 | 2 | C1848640 | |
| Disease | Usher syndrome type 1 | 4.07e-04 | 5 | 190 | 2 | cv:C1568247 | |
| Disease | Seizures | 5.53e-04 | 218 | 190 | 7 | C0036572 | |
| Disease | eye morphology measurement | 5.53e-04 | 218 | 190 | 7 | EFO_0007858 | |
| Disease | Usher Syndrome, Type I | 6.08e-04 | 6 | 190 | 2 | C1568247 | |
| Disease | S-6-hydroxywarfarin measurement | 6.73e-04 | 368 | 190 | 9 | EFO_0803326 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | GABRB2 CDH23 MGAT5 PTPRK PLXNA2 AKAP6 CACNA1D SGIP1 USP28 TACC2 CHFR PLXNA4 MAP2K5 CACNA2D3 | 7.29e-04 | 801 | 190 | 14 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | age at menopause | 7.99e-04 | 302 | 190 | 8 | EFO_0004704 | |
| Disease | Hereditary retinal dystrophy | 8.48e-04 | 7 | 190 | 2 | C0154860 | |
| Disease | LDL cholesterol change measurement | 8.48e-04 | 7 | 190 | 2 | EFO_0007804 | |
| Disease | Usher syndrome | 8.48e-04 | 7 | 190 | 2 | cv:C0271097 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 1.13e-03 | 8 | 190 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 4 measurement | 1.13e-03 | 8 | 190 | 2 | EFO_0801768 | |
| Disease | renin measurement | 1.13e-03 | 8 | 190 | 2 | EFO_0010616 | |
| Disease | Lupus Erythematosus, Systemic | 1.16e-03 | 71 | 190 | 4 | C0024141 | |
| Disease | fatty liver disease (biomarker_via_orthology) | 1.24e-03 | 33 | 190 | 3 | DOID:9452 (biomarker_via_orthology) | |
| Disease | choroid plexus volume measurement | 1.44e-03 | 9 | 190 | 2 | EFO_0010293 | |
| Disease | lifestyle measurement, systolic blood pressure | 1.44e-03 | 9 | 190 | 2 | EFO_0006335, EFO_0010724 | |
| Disease | Cardiomyopathies | 1.57e-03 | 130 | 190 | 5 | C0878544 | |
| Disease | cardiovascular system disease (is_marker_for) | 1.79e-03 | 10 | 190 | 2 | DOID:1287 (is_marker_for) | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 1.79e-03 | 197 | 190 | 6 | EFO_0005680 | |
| Disease | type 2 diabetes mellitus (is_marker_for) | 1.91e-03 | 136 | 190 | 5 | DOID:9352 (is_marker_for) | |
| Disease | Epilepsy, Cryptogenic | 1.97e-03 | 82 | 190 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 1.97e-03 | 82 | 190 | 4 | C0751111 | |
| Disease | Aura | 1.97e-03 | 82 | 190 | 4 | C0236018 | |
| Disease | retinal vasculature measurement | 2.01e-03 | 517 | 190 | 10 | EFO_0010554 | |
| Disease | Profound Mental Retardation | 2.11e-03 | 139 | 190 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.11e-03 | 139 | 190 | 5 | C0025363 | |
| Disease | Mental deficiency | 2.11e-03 | 139 | 190 | 5 | C0917816 | |
| Disease | Semantic-Pragmatic Disorder | 2.18e-03 | 11 | 190 | 2 | C0454655 | |
| Disease | microfibrillar-associated protein 2 measurement | 2.18e-03 | 11 | 190 | 2 | EFO_0801801 | |
| Disease | Auditory Processing Disorder, Central | 2.18e-03 | 11 | 190 | 2 | C0751257 | |
| Disease | visual epilepsy (is_implicated_in) | 2.18e-03 | 11 | 190 | 2 | DOID:11832 (is_implicated_in) | |
| Disease | Language Delay | 2.18e-03 | 11 | 190 | 2 | C0023012 | |
| Disease | Language Development Disorders | 2.18e-03 | 11 | 190 | 2 | C0023014 | |
| Disease | Speech Delay | 2.18e-03 | 11 | 190 | 2 | C0241210 | |
| Disease | diabetes mellitus (is_marker_for) | 2.34e-03 | 41 | 190 | 3 | DOID:9351 (is_marker_for) | |
| Disease | oral microbiome measurement | 2.51e-03 | 42 | 190 | 3 | EFO_0801229 | |
| Disease | Hereditary hearing loss and deafness | 2.61e-03 | 146 | 190 | 5 | cv:C0236038 | |
| Disease | tryptophan betaine measurement | 2.61e-03 | 12 | 190 | 2 | EFO_0021017 | |
| Disease | alcohol consumption measurement | ANKS1B PTPRK MTCH2 PLXNA2 AKAP6 CACNA1D MGAM COL12A1 SGIP1 USP28 PKD1L3 PLXNA4 CCDC25 CTNNA1 HAS3 MAP2K5 CACNA2D3 | 2.89e-03 | 1242 | 190 | 17 | EFO_0007878 |
| Disease | venous thromboembolism | TMPRSS11B CNOT6 HPGD PLCG2 TSEN15 SLC19A2 GEMIN5 PLXNA4 CATSPERB | 3.10e-03 | 460 | 190 | 9 | EFO_0004286 |
| Disease | Gastrointestinal Stromal Sarcoma | 3.46e-03 | 47 | 190 | 3 | C3179349 | |
| Disease | level of Phosphatidylethanolamine (18:1_18:1) in blood serum | 3.57e-03 | 14 | 190 | 2 | OBA_2045142 | |
| Disease | hearing impairment | 3.76e-03 | 98 | 190 | 4 | C1384666 | |
| Disease | RS-10-hydroxywarfarin measurement | 3.76e-03 | 98 | 190 | 4 | EFO_0803330 | |
| Disease | Bipolar Disorder | 3.93e-03 | 477 | 190 | 9 | C0005586 | |
| Disease | coronary artery disease (is_implicated_in) | 4.04e-03 | 100 | 190 | 4 | DOID:3393 (is_implicated_in) | |
| Disease | Down syndrome (implicated_via_orthology) | 4.10e-03 | 15 | 190 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 4.10e-03 | 15 | 190 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | Sinus Node Dysfunction (disorder) | 4.10e-03 | 15 | 190 | 2 | C0428908 | |
| Disease | Gastrointestinal Stromal Tumors | 4.12e-03 | 50 | 190 | 3 | C0238198 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 4.12e-03 | 50 | 190 | 3 | EFO_0022247 | |
| Disease | ceramide measurement | 4.29e-03 | 235 | 190 | 6 | EFO_0010222 | |
| Disease | leprosy | 4.49e-03 | 103 | 190 | 4 | EFO_0001054 | |
| Disease | autism spectrum disorder (is_implicated_in) | 4.66e-03 | 16 | 190 | 2 | DOID:0060041 (is_implicated_in) | |
| Disease | Mood Disorders | 4.74e-03 | 168 | 190 | 5 | C0525045 | |
| Disease | complement factor H-related protein 3 measurement | 4.86e-03 | 169 | 190 | 5 | EFO_0600056 | |
| Disease | C-reactive protein measurement | DUSP12 NCF1 CCDC168 AKAP6 DPYD SGIP1 CD300LF APOB CYFIP2 ARSB ABCB11 IL1RL1 CTNNA1 CTSB PCCB ARHGAP33 | 5.13e-03 | 1206 | 190 | 16 | EFO_0004458 |
| Disease | peak expiratory flow | 5.18e-03 | 498 | 190 | 9 | EFO_0009718 | |
| Disease | memory performance | 5.20e-03 | 409 | 190 | 8 | EFO_0004874 | |
| Disease | Glycogen storage disease | 5.26e-03 | 17 | 190 | 2 | cv:C0017919 | |
| Disease | unipolar depression, response to selective serotonin reuptake inhibitor, mood disorder | 5.26e-03 | 17 | 190 | 2 | EFO_0003761, EFO_0004247, EFO_0005658 | |
| Disease | Streptozotocin Diabetes | 5.30e-03 | 108 | 190 | 4 | C0038433 | |
| Disease | Diabetes Mellitus, Experimental | 5.30e-03 | 108 | 190 | 4 | C0011853 | |
| Disease | Alloxan Diabetes | 5.30e-03 | 108 | 190 | 4 | C0002152 | |
| Disease | Necrosis | 5.39e-03 | 55 | 190 | 3 | C0027540 | |
| Disease | Epilepsy | 5.48e-03 | 109 | 190 | 4 | C0014544 | |
| Disease | serum IgG measurement | 5.90e-03 | 18 | 190 | 2 | EFO_0004565 | |
| Disease | disease free survival | 5.90e-03 | 18 | 190 | 2 | EFO_0000409 | |
| Disease | Libman-Sacks Disease | 6.25e-03 | 58 | 190 | 3 | C0242380 | |
| Disease | physical activity measurement, body mass index | 6.41e-03 | 114 | 190 | 4 | EFO_0004340, EFO_0008002 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YAGILSESMKQVSYL | 936 | Q9HCE0 | |
| FSKSMVLDAYSEYVN | 506 | O15013 | |
| FSKSMVLDVYSDYVN | 401 | Q9HCE6 | |
| YMAPEVLQKGTAYDS | 356 | P35626 | |
| KMETVSGYEAKVYSA | 256 | Q6ZTN6 | |
| GYNSYSVSNSEKDIM | 226 | P07858 | |
| KVYSTKAGMGRYSAV | 471 | Q9H7T0 | |
| AEKGYYTMSNNLVTL | 141 | P29965 | |
| GMYDSSLAAKYLLHS | 111 | O15254 | |
| STVGAGAYAYKTMKE | 76 | O95831 | |
| NGEYLINGKYMISTS | 781 | Q9UNA0 | |
| TLYGSRDSAQMAYLT | 416 | Q6PIY5 | |
| EITAYFMRASSIYSK | 521 | O95267 | |
| QALAKYATTAYMPSE | 1246 | A8K2U0 | |
| YSLRKAYSAAGVSMA | 201 | Q9Y5I7 | |
| AYSAAGVSMAKSYSA | 206 | Q9Y5I7 | |
| KSYSAPRTETAKMYA | 216 | Q9Y5I7 | |
| SEMIKFASYYAGIAV | 136 | O95342 | |
| ALYASKIISYAQGFM | 326 | P52209 | |
| EASMAKYYASEIAGQ | 366 | P45954 | |
| TEYMAKGSLVDYLRS | 266 | P41240 | |
| ITSIANKNYYGAAKM | 101 | Q12882 | |
| NAKYSSVYMEAEATA | 371 | O75952 | |
| YYAMKGAGTDDSTLV | 426 | P20073 | |
| LAETLYYAMKGAGTD | 251 | P08758 | |
| AYPMVAAYSASKFAL | 176 | P28845 | |
| SQYLYTSKAGMSQKE | 126 | O60610 | |
| ANVGYTATYDFKMAD | 301 | Q5VUD6 | |
| YAASKLSYFDKMSNE | 851 | A2RUS2 | |
| DFRYTTTMGVNTYKA | 386 | P00736 | |
| SVLSYYITEGNKDMA | 1561 | Q9H251 | |
| SSDYLLESAKMFNYA | 241 | Q96G23 | |
| TADYATPALKYSMLF | 441 | Q96F81 | |
| YLGMPSKEESTYQAA | 691 | Q8N608 | |
| YTNEYMATHSLTGAK | 201 | Q5SZJ8 | |
| SYSLLAENSYVKMTC | 921 | O14617 | |
| YLVNTYALDSGVSTM | 201 | Q9Y6C9 | |
| LAAAYGMKYIETSAR | 141 | Q96DA2 | |
| GDYTLSTLEQDIMYK | 781 | Q9UHI8 | |
| QALKEDMSGYTIYDT | 96 | Q96AZ6 | |
| FVTALYMTDIKNDSY | 66 | Q9NXK6 | |
| YSLDQDKMTSLFYTL | 266 | Q8NH69 | |
| YAIYGFLKMSDTLAV | 416 | Q7Z304 | |
| KEACLTQGMTLYSYG | 171 | Q06481 | |
| YTKAFLINGYTSMDL | 901 | Q7Z6G8 | |
| LADQIFAYYKVMAGS | 706 | Q7L576 | |
| TLIMAYDYAKEVNSA | 291 | Q96JP0 | |
| TPQYVDDMDGLYTKS | 446 | Q5SY16 | |
| DQVINSAAKTYYMSG | 121 | P11177 | |
| SMKRGQEYTDYINAS | 471 | P23469 | |
| ALAKADSYTLAAMAY | 106 | Q9Y585 | |
| STAKFMGNSYIKYID | 2976 | Q5T1H1 | |
| MNETTAVALAYGIYK | 171 | P34932 | |
| ENVFTGQSKIYSYMS | 86 | Q9NQR1 | |
| TYMEVHATVYGSSTK | 471 | Q09328 | |
| ASQNFSYGVTEMYKA | 361 | Q9H9P8 | |
| KSSKAYYVLSDAAMS | 691 | Q3B7T1 | |
| RFGTMTYLSKAAATY | 1196 | P46020 | |
| FAYYQEAKSTNIMSS | 161 | P54707 | |
| LSASMYTSQKRYGLA | 1391 | Q9Y3R5 | |
| YGYSMAVATAEAAKT | 586 | O43451 | |
| KYTERDGSAMVYNLA | 486 | Q8N568 | |
| EHYLSSVNKTGTMYG | 156 | O75051 | |
| TSASKYENMIRYTGS | 1616 | Q9HCM2 | |
| TMSALSEIFSYVGKY | 1846 | Q9HCM2 | |
| SIAKTYVGTNAYMAP | 311 | Q13163 | |
| YRAIANYEKTSGSEM | 161 | P14598 | |
| NGTSSMAVIKDYYAL | 2321 | O60229 | |
| DMVSGLIYKTYTLQD | 26 | Q96J66 | |
| SGSMLYIKFTSDYAR | 116 | O60462 | |
| ITYAYTGNLAMNDST | 86 | Q8IY47 | |
| ASVKAQSMLGLYYST | 171 | Q9P2M1 | |
| MLAYDASSIQYRKAG | 431 | P47870 | |
| IIGYSQVDKMASLYN | 401 | Q96EN8 | |
| TMEGGTLKYYLTDNL | 591 | P16885 | |
| ADQIFAYYKAMAGSV | 731 | Q96F07 | |
| NSSAYTIYMGKDKYE | 11 | Q86WR0 | |
| LSAAKMVYYLDPSSQ | 766 | Q9BXJ9 | |
| MFTYDYDTALQSKAA | 821 | Q68CR7 | |
| TKTGNALPMFYVYDS | 256 | Q5SRI9 | |
| ASNMEGKAQKYYFLS | 3226 | Q96RW7 | |
| SAADQAKMYSLFYTI | 266 | P0C628 | |
| TRKAYGGAYDVMSSK | 431 | P05166 | |
| LTYQLYGKFSEAMSV | 401 | O14559 | |
| SNIVGKAHSDYMLYV | 316 | Q9BY67 | |
| GMKVYIYSSGSVEAQ | 146 | Q9UHY7 | |
| KYDFNSSMLYSTAKG | 3461 | P04114 | |
| AMLADYFKYPSSVSA | 326 | Q8IUR7 | |
| VAYLYESLSEKQGMT | 116 | Q96EP1 | |
| YGDSEKMTYTEQASK | 416 | Q9C0G6 | |
| YLMYSTVSGSEKNSK | 116 | Q01638 | |
| LYMSTKNTILKAYDG | 246 | P48735 | |
| DKQYFGSYSAKMNLV | 126 | O75054 | |
| AAATNLSALYYMGKD | 451 | Q13099 | |
| LSALYYMGKDFAQAS | 456 | Q13099 | |
| YMGKDFAQASSYADI | 461 | Q13099 | |
| VKSMNLIGQGTFSYY | 121 | Q2UY09 | |
| SYVASTKYQKSQGMA | 836 | P35221 | |
| YTSPGFKMLEAYNLT | 2516 | Q99715 | |
| TMGSFKRITLYDYQA | 891 | Q8IZS8 | |
| NSKLYESLTYSQMSR | 1636 | Q8TD26 | |
| GMEKFTNYSVQVLAY | 1156 | Q8TD84 | |
| SGLMVATKYEVSVYA | 1871 | P02751 | |
| KYYGAQTVRSTMNFK | 66 | P07954 | |
| YVTMASLPKEDISYA | 236 | Q8TDQ1 | |
| GTTAAVPYTEEAYMK | 411 | Q5VU57 | |
| ESAVTGYKMLYQNDL | 941 | Q02246 | |
| YKLENLSSSEMGYTA | 136 | P10253 | |
| TEKTLYLVMEYASGG | 121 | Q7KZI7 | |
| EVATGYKNMYSTNIF | 201 | P15848 | |
| GYYLTKALTGHNMSE | 481 | Q8NA03 | |
| AAMGISVTAKDYRVY | 116 | Q8IYD2 | |
| SVTAKDYRVYAAGGM | 121 | Q8IYD2 | |
| EKYSVTQLVYSASMD | 656 | Q9UHC6 | |
| VMYTAFKALGDSVDY | 196 | O00219 | |
| GMSLYYSQVRKAVDN | 551 | Q5TBA9 | |
| YLNDITGDSNRTKYM | 4616 | Q8NDH2 | |
| KAVSTTGYDMARNAY | 141 | P60008 | |
| QLKLYQAMGYEVDTS | 161 | Q9UNI6 | |
| QAMGYEVDTSSAIYK | 166 | Q9UNI6 | |
| YLNMRSTYAKLAAVA | 186 | O75396 | |
| KMATAAAFTISYVYS | 426 | Q9Y226 | |
| TMSGKVYANISSYNA | 501 | P46059 | |
| YSVVDLGMYQKVTSY | 146 | O60779 | |
| TSEAYQKYNSGVTMG | 596 | Q9Y2W3 | |
| AVSAYSSAMRLKSVY | 556 | Q8IZU8 | |
| VLYKMTADDQRYSGS | 791 | P54277 | |
| EAMAVTAYHQYSKGI | 341 | Q8TDX9 | |
| LVKMYSLGLQAYFVS | 571 | Q01668 | |
| DMLYAASSIKSNYLV | 311 | Q08AD1 | |
| FKLQSAYESGLMPYT | 466 | Q9ULM6 | |
| GYNIYFQAMSSVEKE | 706 | Q15262 | |
| GKNYSMSVYLVRQLT | 286 | O75928 | |
| MRPLATAYKASTSDY | 286 | Q8NFH5 | |
| VISGTYLGLDYMSKQ | 111 | P15428 | |
| KFQAAYSLTYNTIAM | 366 | P58004 | |
| MSKVADSLLSYTEQY | 276 | P49802 | |
| AYTRAIMGSGKEDYT | 176 | P52788 | |
| IVTMDYAAQKYVGTH | 206 | Q9BZE2 | |
| MEGLTLSDAEQKYYS | 1 | Q96D71 | |
| QTMFSAYLGSEQYKL | 166 | Q9H061 | |
| KMDAVVNFTYQYLSA | 501 | Q8N3T6 | |
| TSGSDKINYTYMLTR | 191 | O15226 | |
| SYLMGYNKSLSVVAT | 186 | Q96RN1 | |
| MTAIYSAKNSNRFYL | 1296 | Q7Z443 | |
| LLLTVKSMDGYESYG | 821 | O15357 | |
| SNSEMVLYSYSIGFV | 256 | Q9H1N7 | |
| NYLSMLDTVSGNSVY | 411 | Q07837 | |
| NKMSNYSLLSVDYVV | 226 | Q06520 | |
| RGSNYTSKYLGMTLA | 86 | P20701 | |
| ATVKRMYIYSGNSLQ | 166 | Q9BSU1 | |
| SKLFDISMAISYLYN | 136 | Q9UBF8 | |
| SMRSITTKLYDGFQY | 796 | Q9UBF8 | |
| SGEQTYYDLVKAFMA | 196 | Q07889 | |
| GIFIKDSNSLAYYNM | 761 | Q15459 | |
| VMNGSIKGSNYTYLS | 2781 | Q4LDE5 | |
| HNKSATYSVGMQKTY | 601 | Q8IUC4 | |
| LYAACSISYLGAMVS | 86 | P78383 | |
| EVKKEYASMYSGNDS | 126 | Q7Z7C7 | |
| MAKSYYEANDVTSAI | 296 | Q9Y5Q9 | |
| TLLFSQGKMYGYVDT | 541 | Q9Y5Q9 | |
| EQMSLKLYSEQYTSS | 926 | Q13023 | |
| LMNTSSALYRSYKTD | 186 | Q8IZF2 | |
| KYMKRYGLLQSSDNS | 1121 | Q15468 | |
| DVVKTRYMNSALGQY | 236 | P55851 | |
| SYVLKNGESLSMDYI | 1906 | Q96RL7 | |
| TLLFYETYGKNSMDQ | 546 | Q8IVF5 | |
| NASYAYSGFVTDTML | 336 | Q86T26 | |
| YYQALSSSSIMNKEG | 146 | P28289 | |
| NLGTAMTYTLFEYAK | 91 | Q6NW29 | |
| MNETTAVALAYGIYK | 171 | O95757 | |
| DYKYNTDAMTTAVAL | 706 | Q9BQI5 | |
| TYDLVYEQAMKGTSH | 126 | Q96QS1 | |
| LSYLMASGSNNAVIY | 596 | Q8TEQ6 | |
| SAYRSAASKTMNIYF | 521 | Q9Y263 | |
| LSMKYKGYVNSSSQI | 776 | Q5JSH3 | |
| NSYEIEYMEKIGSSL | 2521 | O95359 | |
| LVYAYQSNAALLMKG | 921 | Q96RU2 | |
| EMTGKLISSYYNVTY | 46 | Q96SK2 | |
| KQEKSMYGVYNTFTT | 121 | Q6IQ21 | |
| VGENSLEYSEYMTGK | 136 | Q96MM3 | |
| KALSSMGANYSSYLA | 156 | P45378 | |
| MGANYSSYLAKADQK | 161 | P45378 | |
| YQLGSVYSAAMVTAL | 826 | Q8TEQ8 | |
| ISTLNMSKIGYFYTD | 36 | Q969U7 | |
| SEYISSDGSYARMKA | 151 | P17014 | |
| TDTYKAITYNAMLAE | 176 | Q9BUB7 | |
| ASLIKAMTYYGNLDS | 611 | Q8TE54 | |
| GNYESLVSMDYAISK | 316 | Q9ULD5 | |
| QEMKTNYETLDSLGY | 36 | Q6IV72 | |
| ITLMEYYSKEALGDS | 826 | Q69YN4 | |
| KTYDMLKAGTTATYE | 106 | Q99959 | |
| SDSTIVYYKLTDGFM | 146 | Q8WW01 | |
| IVSAYMHYSKISAGA | 241 | Q63HR2 | |
| IYSQFRGYLMKSLQT | 311 | Q8NHX9 | |
| DASLYSKRYNQSMVT | 1016 | Q6EMB2 | |
| MSQVKSSYSYDAPSD | 1 | Q9ULW0 | |
| GISSMDIAYTYDRSK | 521 | Q9UQQ1 | |
| AAKYIMSYISRVSGG | 121 | Q12965 | |
| AEQKHSLGITSMDYY | 221 | Q12965 | |
| VSAKYAMRYFATVSG | 171 | Q9Y4I1 | |
| MYIKASGSYAVQEKP | 286 | Q96BF6 | |
| LGYKMDDLLTSYISQ | 2186 | Q13402 | |
| AKDYMNGTGRYTVVK | 31 | Q9HAN9 |